Your browser doesn't support javascript.
loading
A European Bioanalysis Forum recommendation for requiring a context-of-use statement for successful development and validation of biomarker assays.
Cowan, Kyra J; Kunz, Ulrich; Blattmann, Peter; Gulati, Pratiksha; Hughes, Richard; Andersen, Lene; Goodman, Joanne; Lambert, Frazer; Lawrence, James; Thwaites, Daniel; Golob, Michaela; Nelson, Robert; Timmerman, Philip.
Afiliação
  • Cowan KJ; Merck KGaA, Research & Development, Drug Metabolism & Pharmacokinetics New Biological Entities, 64293Darmstadt, Germany.
  • Kunz U; Boehringer Ingelheim Pharma GmbH & Co. KG, Translational Medicine & Clinical Pharmacology, 88400Biberach an der Riss, Germany.
  • Blattmann P; Idorsia Pharmaceuticals Ltd, Translational Sciences, 4123Allschwil, Switzerland.
  • Gulati P; F. Hoffmann La Roche Ltd Bioanalysis & Biomarkers Chapter, Pharmaceutical Sciences, 4070Basel, Switzerland.
  • Hughes R; Resolian Bioanalytics, Newmarket Road, Fordham,  CB7 5WW, United Kingdom.
  • Andersen L; Novo Nordisk A/S, Clinical LCMS Bioanalysis, DK-2760, Maaløv, Denmark.
  • Goodman J; Bioanalytical Services, Celerion, Lincoln, NE 68502, USA.
  • Lambert F; Charles River Laboratories, Immunology, Bioanalysis & Biomarkers, EH33 2NE, Edinburgh, United Kingdom.
  • Lawrence J; Invox Pharma, Translational Sciences, CB21 6AD, Cambridge, United Kingdom.
  • Thwaites D; LabCorp Drug Development, LabCorp Drug Development, Immunology & Immunotoxicology, HG3 1PY, Harrogate, United Kingdom.
  • Golob M; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany.
  • Nelson R; BioAgilytix Laboratories, 22339Hamburg, Germany.
  • Timmerman P; European Bioanalysis Forum vzw (EBF), Havenlaan 86c b204, 1000Brussels, Belgium.
Bioanalysis ; : 1-8, 2024 Aug 05.
Article em En | MEDLINE | ID: mdl-39101487
ABSTRACT
The European Bioanalysis Forum, alongside key industry stakeholders, has been driving the discussions around the implementation of context-of use for biomarker assays to ensure that these assays are validated appropriately depending on their purpose. Insights into understanding why the implementation of context-of-use in assay strategies has also shown that the key stakeholder, or requester for the biomarker data, is responsible for providing the context-of-use statement for all biomarker assay requests. Experts from across the industry haves repeatedly sought a cross-industry recommended format in which the context-of-use statement could be provided. In this manuscript, the European Bioanalysis Forum suggests a format for this.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioanalysis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Bioanalysis Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
...